The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dignity Plc

17 Apr 2023 13:53

RNS Number : 4693W
Schroders PLC
17 April 2023
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Schroders PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dignity PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

14/04/2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

12 48/143p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

0

0

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

12 48/143p ordinary

Sale

2.323.576

5.50 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

17/04/2023

Contact name:

Lauren Weatherall-Brown

Telephone number:

+442076582540

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETLDLFFXZLEBBL
Date   Source Headline
17th Oct 202211:05 amRNSNotification of Major Holdings
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results
29th Sep 202211:31 amRNSResults of Consent Solicitation with Bondholders
15th Sep 20228:37 amRNSChange in Director’s Particulars
15th Sep 20227:00 amRNSUpdate to release date of 2022 Half-Year Results
7th Sep 20223:55 pmRNSConsent solicitation with Noteholders
31st Aug 20228:55 amRNSVoting Rights and Capital
29th Jul 202210:01 amRNSVoting Rights and Capital
29th Jul 20227:46 amRNSFCA Regulation
20th Jul 20229:00 amRNSDignity Announces Aim to be Net Zero By 2038
30th Jun 20224:50 pmRNSVoting Rights and Capital
17th Jun 20227:25 amRNS“intending to authorise” status from the FCA
14th Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jun 20223:12 pmRNSBoard Update
9th Jun 202212:54 pmRNSResults of AGM
6th Jun 20227:00 amRNSNotification of Major Holdings
31st May 20227:00 amRNSVoting Rights and Capital
27th May 20222:52 pmRNSChange in Director’s Particulars
16th May 20227:00 amRNSAppointment of Chief Executive Officer
11th May 20227:00 amRNSFirst Quarter Trading Update
3rd May 202210:41 amRNSNotification of Major Holdings
29th Apr 20228:04 amRNS2021 Annual Report & Notice of 2022 AGM
29th Apr 20227:00 amRNSVoting Rights and Capital
14th Apr 202210:24 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th Apr 202210:59 amRNSDirectorate Change
31st Mar 20227:00 amRNSTotal Voting Rights
30th Mar 202212:34 pmRNSNotification of Major Holdings
23rd Mar 20227:00 amRNSPreliminary Results
11th Mar 202211:49 amRNSResults of Bondholders Consent Solicitation
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSVoting Rights and Capital
17th Feb 202210:30 amRNSTrading Update & Consent solicitation period
14th Feb 20227:00 amRNSNotification of Preliminary Results
12th Jan 202212:57 pmRNSBoard Appointment
7th Jan 20223:30 pmRNSBoard Appointments
31st Dec 20217:00 amRNSVoting Rights and Capital
17th Dec 20218:49 amRNSDirector Dealing Notification
14th Dec 202110:16 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSVoting Rights and Capital
8th Nov 20217:00 amRNSQ3 Trading Update
21st Oct 20217:00 amRNSAppointment of Joint Broker
14th Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20217:00 amRNSVoting Rights and Capital
21st Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSBoard Appointment
26th Jul 20217:00 amRNSBoard Appointment
12th Jul 20217:00 amRNSUpdate to release date of 2021 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.